Madis I.
- Country
- Estonia
- Department
- N/A
Research Overview
- A Phase 1, open-label, non-comparative, multicenter clinical study to evaluate the safety, tolerability, and pharmacokinetics of ceftolozane/tazobactam (MK-7625A) in pediatric participants with nosocomial pneumonia
- Evaluation of Sparsentan Versus Irbesartan on Renal Outcomes in Patients with Primary Focal Segmental Glomerulosclerosis (FSGS)
- Efficacy and Safety Evaluation of Sparsentan in Patients with Immunoglobulin A Nephropathy: A Randomized, Double-Blind, Active-Controlled Study
Data & Insights
Has run more than one trial at 43 of 237 partner sites.
Specializations
Cardiovascular Nephrology
The investigator specializes in studying atherosclerotic cardiovascular disease in patients with end-stage kidney disease (ESKD). Their research focuses on innovative therapeutic approaches for patients undergoing maintenance dialysis, with particular attention to inflammatory markers like high-sensitivity C-reactive protein.
- Cardiovascular complications in ESKD
- Dialysis-related cardiovascular outcomes
- Inflammatory biomarkers
Their work explores the intersection of cardiovascular health and renal disease in dialysis patients.
Glomerular Diseases
The investigator conducts research in Immunoglobulin A Nephropathy (IgAN), investigating novel therapeutic approaches. Their work examines treatments aimed at reducing proteinuria and preserving renal function, with a focus on alternatives to conventional angiotensin receptor blocker therapy.
- IgA Nephropathy treatment
- Proteinuria management
- Renal function preservation
Their research emphasizes long-term nephroprotective strategies in glomerular diseases.
Rare Kidney Disorders
The investigator studies Focal Segmental Glomerulosclerosis (FSGS), including both primary and genetic forms. Their research evaluates innovative therapeutic approaches for this rare kidney condition, focusing on nephroprotective treatments and long-term disease management.
- Primary FSGS treatment
- Genetic FSGS research
- Novel therapeutic approaches
Their work contributes to advancing treatment options for rare glomerular disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.